IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i23p15902-d987587.html
   My bibliography  Save this article

Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication—MoPIM Cohort Study

Author

Listed:
  • Marina Lleal

    (Institutional Committee for the Improvement of Clinical Practice Adequacy, Clinical Epidemiology and Cancer Screening Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain
    Department of Paediatrics, Obstetrics and Gynaecology, Preventive Medicine and Public Health, Autonomous University of Barcelona (UAB), 08193 Bellaterra, Catalonia, Spain)

  • Marisa Baré

    (Institutional Committee for the Improvement of Clinical Practice Adequacy, Clinical Epidemiology and Cancer Screening Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain
    Research Network on Health Services in Chronic Patients (REDISSEC), ISCIII, 28029 Madrid, Spain
    Research Network on Chronicity, Primary Care and Health Promotion (RICAPPS), ISCIII, 28029 Madrid, Spain)

  • Sara Ortonobes

    (Pharmacy Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain)

  • Daniel Sevilla-Sánchez

    (Pharmacy Department, Parc Sanitari Pere Virgili, 08023 Barcelona, Catalonia, Spain)

  • Rosa Jordana

    (Internal Medicine Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain)

  • Susana Herranz

    (Acute Care Geriatric Unit, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain)

  • Maria Queralt Gorgas

    (Pharmacy Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT), 08208 Sabadell, Catalonia, Spain)

  • Mariona Espaulella-Ferrer

    (Geriatrics Department, Consorci Hospitalari de Vic, 08500 Vic, Catalonia, Spain)

  • Marta Arellano

    (Geriatrics Department, Consorci Parc de Salut MAR, 08003 Barcelona, Catalonia, Spain)

  • Marta de Antonio

    (Pharmacy Department, Consorci Parc de Salut MAR, 08003 Barcelona, Catalonia, Spain)

  • Gloria Julia Nazco

    (Pharmacy Department, Hospital Universitario de Canarias, 38320 La Laguna, Canarias, Spain)

  • Rubén Hernández-Luis

    (Internal Medicine Department, Hospital Universitario de Canarias, 38320 La Laguna, Canarias, Spain)

  • on behalf of the MoPIM Study Group

    (Collaborators/Membership of the Group/Team Name is provided in the Acknowledgments.)

Abstract

Multimorbidity is increasing and poses a challenge to the clinical management of patients with multiple conditions and drug prescriptions. The objectives of this work are to evaluate if multimorbidity patterns are associated with quality indicators of medication: potentially inappropriate prescribing (PIP) or adverse drug reactions (ADRs). A multicentre prospective cohort study was conducted including 740 older (≥65 years) patients hospitalised due to chronic pathology exacerbation. Sociodemographic, clinical and medication related variables (polypharmacy, PIP according to STOPP/START criteria, ADRs) were collected. Bivariate analyses were performed comparing previously identified multimorbidity clusters (osteoarticular, psychogeriatric, minor chronic disease, cardiorespiratory) to presence, number or specific types of PIP or ADRs. Significant associations were found in all clusters. The osteoarticular cluster presented the highest prevalence of PIP (94.9%) and ADRs (48.2%), mostly related to anxiolytics and antihypertensives, followed by the minor chronic disease cluster, associated with ADRs caused by antihypertensives and insulin. The psychogeriatric cluster presented PIP and ADRs of neuroleptics and the cardiorespiratory cluster indicators were better overall. In conclusion, the associations that were found reinforce the existence of multimorbidity patterns and support specific medication review actions according to each patient profile. Thus, determining the relationship between multimorbidity profiles and quality indicators of medication could help optimise healthcare processes. Trial registration number: NCT02830425.

Suggested Citation

  • Marina Lleal & Marisa Baré & Sara Ortonobes & Daniel Sevilla-Sánchez & Rosa Jordana & Susana Herranz & Maria Queralt Gorgas & Mariona Espaulella-Ferrer & Marta Arellano & Marta de Antonio & Gloria Jul, 2022. "Comprehensive Multimorbidity Patterns in Older Patients Are Associated with Quality Indicators of Medication—MoPIM Cohort Study," IJERPH, MDPI, vol. 19(23), pages 1-16, November.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:23:p:15902-:d:987587
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/23/15902/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/23/15902/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Cathal A. Cadogan & Cristín Ryan & Carmel M. Hughes, 2016. "Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many," Drug Safety, Springer, vol. 39(2), pages 109-116, February.
    2. Jonás Carmona-Pírez & Ignatios Ioakeim-Skoufa & Antonio Gimeno-Miguel & Beatriz Poblador-Plou & Francisca González-Rubio & Dolores Muñoyerro-Muñiz & Juliana Rodríguez-Herrera & Juan Antonio Goicoechea, 2022. "Multimorbidity Profiles and Infection Severity in COVID-19 Population Using Network Analysis in the Andalusian Health Population Database," IJERPH, MDPI, vol. 19(7), pages 1-13, March.
    3. Mingkwan Na Takuathung & Wannachai Sakuludomkan & Rapheephorn Khatsri & Nahathai Dukaew & Napatsorn Kraivisitkul & Balqis Ahmadmusa & Chollada Mahakkanukrauh & Kachathip Wangthaweesap & Jirakit Onin &, 2022. "Adverse Effects of Angiotensin-Converting Enzyme Inhibitors in Humans: A Systematic Review and Meta-Analysis of 378 Randomized Controlled Trials," IJERPH, MDPI, vol. 19(14), pages 1-13, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Dirk Heider & Herbert Matschinger & Andreas D Meid & Renate Quinzler & Jürgen-Bernhard Adler & Christian Günster & Walter E Haefeli & Hans-Helmut König, 2018. "The impact of potentially inappropriate medication on the development of health care costs and its moderation by the number of prescribed substances. Results of a retrospective matched cohort study," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-12, July.
    2. Ignatios Ioakeim-Skoufa & Mercedes Clerencia-Sierra & Aida Moreno-Juste & Carmen Elías de Molins Peña & Beatriz Poblador-Plou & Mercedes Aza-Pascual-Salcedo & Francisca González-Rubio & Alexandra Prad, 2022. "Multimorbidity Clusters in the Oldest Old: Results from the EpiChron Cohort," IJERPH, MDPI, vol. 19(16), pages 1-15, August.
    3. Eun-Hae Lee & Ju-Ok Park & Joon-Pil Cho & Choung-Ah Lee, 2021. "Prioritising Risk Factors for Prescription Drug Overdose among Older Adults in South Korea: A Multi-Method Study," IJERPH, MDPI, vol. 18(11), pages 1-11, June.
    4. Catarina Caçador & Edite Teixeira-Lemos & Jorge Oliveira & João Pinheiro & Luís Teixeira-Lemos & Fernando Ramos, 2022. "The Prevalence of Polypharmacy and Potentially Inappropriate Medications and Its Relationship with Cognitive Status in Portuguese Institutionalized Older Adults: A Cross-Sectional Study," IJERPH, MDPI, vol. 19(5), pages 1-13, February.
    5. Derek Stewart & Kathrine Gibson-Smith & Katie MacLure & Alpana Mair & Albert Alonso & Carles Codina & Antonio Cittadini & Fernando Fernandez-Llimos & Glenda Fleming & Dimitra Gennimata & Ulrika Gilles, 2017. "A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people," PLOS ONE, Public Library of Science, vol. 12(11), pages 1-17, November.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:23:p:15902-:d:987587. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.